Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 2/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.31 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL450544 | 0.78 | MEN1 (0.32) | — | |
| SCHEMBL6576734 | 0.76 | FDPS (0.39) | — | |
| SCHEMBL11146828 | 0.75 | EPHX1 (0.31) | — | |
| SCHEMBL6666010 | 0.74 | GABRR1 (0.34) | GABRR1 | |
| SCHEMBL5419816 | 0.73 | FDPS (0.42) | GABRR1 | |
| SCHEMBL132663 | 0.71 | TET2 (0.34) | — | |
| SCHEMBL8677645 | 0.69 | TET2 (0.33) | GRM2GRM3 | |
| Chloromethane SCHEMBL534660 | 0.69 | TET2 (0.33) | — | |
| SCHEMBL2199441 | 0.69 | ODC1 (0.36) | GABRR1CYP2D6 | |
| SCHEMBL6577497 | 0.68 | TET2 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9855531-B2 | Polymer membrane for water treatment and method for manufacture of same, and water treatment method | SEKISUI CHEMICAL CO., LTD. (JP) | 2018-01-02 | — | — | US | disclosed |
| US-20160030892-A1 | POLYMER MEMBRANE FOR WATER TREATMENT AND METHOD FOR MANUFACTURE OF SAME, AND WATER TREATMENT METHOD | SEKISUI CHEMICAL CO LTD (JP) | 2016-02-04 | — | — | US | disclosed |
| US-20040208834-A1 | Oral-use polymer and oral-use composition | KAO CORPORATION (JP) | 2004-10-21 | — | — | US | disclosed |
| EP-1413589-A1 | POLYMERS FOR ORAL USE AND COMPOSITIONS FOR ORAL USE | Kao Corporation (JP) | 2004-04-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040208834-A1 | Oral-use polymer and oral-use composition | PHOSPHO1, PPA1, PHPT1 | GABRR1 1208/4885GRM2 761/4885GRM3 1211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.